- Titled “Relax, it’s a blood test”
- Novartis and NFL Stars Launch Prostate Cancer Awareness Campaign at Super Bowl LX
EAST HANOVER, United States – Novartis, in partnership with the NFL, announced on January 29 a new national prostate cancer awareness campaign, “Relax, it’s a blood test,” which will feature a commercial during Super Bowl LX.
This story was produced by our AI newsroom. Learn about our verification process.
What is new?
Novartis, the official pharmaceutical partner of the NFL, has launched a new national initiative aimed at raising awareness for prostate cancer.
Titled “Relax, it’s a blood test,” the campaign will debut with a commercial airing during Super Bowl LX on February 8, 2026. The effort seeks to correct common misperceptions about prostate cancer screening and promote early detection through a simple prostate-specific antigen (PSA) blood test.
Listen to the audio summary:
Campaign Details
The campaign features a collaboration with eight NFL figures, including Super Bowl-winning coach and prostate cancer survivor Bruce Arians, tight ends George Kittle and Colby Parkinson, and NFL legends Rob Gronkowski, Greg Olsen, Tony Gonzalez, Delanie Walker, and Vernon Davis. Each participant has a personal connection to the cause and aims to normalize conversations about men’s health.
Novartis has also partnered with several patient advocacy organizations, including the American Cancer Society and ZERO Prostate Cancer. The initiative will provide an online educational hub with a risk assessment tool, guidance on testing, and will host screening events with NFL teams and at the Super Bowl Experience.
The Need for Awareness
Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among American men.
Early detection offers a greater than 99% five-year survival rate, yet many men avoid screening. A significant barrier is the misconception that screening requires an invasive digital rectal exam, while the initial step is a PSA blood test.
An estimated 40.3 million age-eligible men in the U.S. have never had a PSA test. The campaign highlights that Black men face a higher risk of diagnosis, underscoring the need for greater education. Current guidelines recommend most men begin discussing screening with a doctor at age 45, or age 40 for high-risk groups.
About this company
Novartis is an innovative medicines company. The company states its work is to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. According to the company, its medicines reach nearly 300 million people worldwide.
Read more
FDA Approves Novartis’s Kisqali For High-Risk Early Breast Cancer
Novartis Kisqali Gets Positive Chmp Opinion For Reducing Recurrence In Breast Cancer
Novartis Launches Tender Offer to Acquire Tourmaline Bio for $48 Per Share